- Home
- BCYC vs CEVA Comparison
BCYC vs CEVA Comparison
Compare BCYC & CEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- CEVA
- Stock Information
- Founded
- BCYC 2009
- CEVA 1999
- Country
- BCYC United Kingdom
- CEVA United States
- Employees
- BCYC N/A
- CEVA N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- CEVA Semiconductors
- Sector
- BCYC Health Care
- CEVA Technology
- Exchange
- BCYC Nasdaq
- CEVA Nasdaq
- Market Cap
- BCYC 565.5M
- CEVA 642.7M
- IPO Year
- BCYC 2019
- CEVA 2000
- Fundamental
- Price
- BCYC $8.76
- CEVA $26.93
- Analyst Decision
- BCYC Buy
- CEVA Strong Buy
- Analyst Count
- BCYC 11
- CEVA 5
- Target Price
- BCYC $22.91
- CEVA $35.60
- AVG Volume (30 Days)
- BCYC 284.7K
- CEVA 283.6K
- Earning Date
- BCYC 10-31-2025
- CEVA 11-10-2025
- Dividend Yield
- BCYC N/A
- CEVA N/A
- EPS Growth
- BCYC N/A
- CEVA N/A
- EPS
- BCYC N/A
- CEVA N/A
- Revenue
- BCYC $19,281,000.00
- CEVA $106,353,000.00
- Revenue This Year
- BCYC N/A
- CEVA $4.35
- Revenue Next Year
- BCYC N/A
- CEVA $15.50
- P/E Ratio
- BCYC N/A
- CEVA N/A
- Revenue Growth
- BCYC N/A
- CEVA 7.71
- 52 Week Low
- BCYC $6.10
- CEVA $18.31
- 52 Week High
- BCYC $25.39
- CEVA $38.94
- Technical
- Relative Strength Index (RSI)
- BCYC 56.40
- CEVA 50.32
- Support Level
- BCYC $7.65
- CEVA $25.44
- Resistance Level
- BCYC $8.75
- CEVA $29.20
- Average True Range (ATR)
- BCYC 0.45
- CEVA 1.32
- MACD
- BCYC -0.03
- CEVA -0.20
- Stochastic Oscillator
- BCYC 55.56
- CEVA 37.10
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About CEVA CEVA Inc.
CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived primarily from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems.